Published in Am J Physiol on December 01, 1997
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature (1997) 9.71
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (1997) 8.38
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
Gas-bubble lesions in stranded cetaceans. Nature (2003) 5.95
RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell (1991) 5.89
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2000) 5.07
Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev (1999) 4.92
Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science (1998) 4.55
Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature (1999) 4.32
The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell (1991) 4.27
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A (2000) 3.89
Transport of live animals for slaughter. Vet Rec (1991) 3.83
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev (1998) 3.79
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA (1998) 3.57
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature (1988) 3.42
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet (1999) 3.34
Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta (1983) 3.29
Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol (1999) 3.11
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A (2000) 2.92
Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev (1999) 2.92
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 2.92
The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1996) 2.85
Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem (2001) 2.70
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature (1998) 2.65
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A (1997) 2.63
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell (1998) 2.60
The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med (1995) 2.59
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55
Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem (1983) 2.50
A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol (1996) 2.47
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (1994) 2.43
A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J (1983) 2.42
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A (1996) 2.39
Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc (1985) 2.27
Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 2.23
Signal-specific co-activator domain requirements for Pit-1 activation. Nature (1998) 2.22
Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A (2000) 2.17
Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol (2000) 2.12
Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev (1993) 2.11
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science (1991) 2.11
Effect of natural genetic variation on enhancer selection and function. Nature (2013) 2.10
Differential use of CREB binding protein-coactivator complexes. Science (1998) 2.10
Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev (2001) 2.09
The 'Ryan virus'. Parasitol Today (1989) 2.02
Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem (1998) 2.02
Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed) (1983) 2.01
The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol (1996) 1.82
Heteroplasmic point mutations in the human mtDNA control region. Am J Hum Genet (1996) 1.78
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem (1983) 1.77
Imaging subcortical auditory activity in humans. Hum Brain Mapp (1998) 1.74
Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature (1984) 1.69
Variation in the degree of synchronization exhibited by motor units lying in different finger muscles in man. J Physiol (1991) 1.62
Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood (1995) 1.60
RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat Genet (1999) 1.56
The primary structure of link protein from rat chondrosarcoma proteoglycan aggregate. J Biol Chem (1986) 1.56
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
HLA antigen contamination of commercial Western blot strips for detecting human immunodeficiency virus. J Infect Dis (1989) 1.52
Correlation between the discharges of motor units recorded from the same and from different finger muscles in man. J Physiol (1991) 1.52
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. Proc Natl Acad Sci U S A (2000) 1.51
Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol (1988) 1.51
A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis (1999) 1.51
Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol (1994) 1.49
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol (1997) 1.49
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet (2001) 1.48
Bleomycin-induced interstitial pneumonia in dogs. Thorax (1971) 1.47
The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol (1996) 1.47
O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol (1997) 1.47
Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J Biol Chem (1993) 1.46
Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans. J Biol Chem (1980) 1.45
A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res (2001) 1.44
Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci U S A (1997) 1.41
Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ (1995) 1.41
Diffuse alveolar damage in the horse. Equine Vet J (1995) 1.39
Enhanced two-photon biosensing with double-clad photonic crystal fibers. Opt Lett (2003) 1.37
Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol (1994) 1.37
Clinical spectrum of pulmonary mucormycosis. Chest (1986) 1.35
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res (1996) 1.32
Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J Biol Chem (1994) 1.29
The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol (1999) 1.28
Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol (2000) 1.26
Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials (2000) 1.26
Cytotoxicity of antibody-coated trypanosomes by normal human lymphoid cells. Nature (1976) 1.25
The isolation and characterization of the link proteins from proteoglycan aggregates of bovine nasal cartilage. J Biol Chem (1979) 1.25
Immune mechanisms in Graves' disease. Endocr Rev (1985) 1.25
Biosynthesis of chondroitin sulfate proteoglycan. Xylosyl transfer to Smith-degraded cartilage proteoglycan and other exogenous acceptors. J Biol Chem (1972) 1.24
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia (2009) 1.22
Deformability of poly(amidoamine) dendrimers. Eur Phys J E Soft Matter (2004) 1.21
Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycan. J Biol Chem (1985) 1.21
Cartilage proteoglycan aggregates. The link protein and proteoglycan amino-terminal globular domains have similar structures. J Biol Chem (1987) 1.20
Salmonellosis in the horse. Br Vet J (1970) 1.19
Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J Immunol (1987) 1.17
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J Clin Invest (2000) 1.16